{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T02:36:08Z","timestamp":1795142168044,"version":"4.10.3"},"reference-count":55,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,3,16]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Ex vivo drug profiling captures disease-relevant features and relevant sensitivity to therapeutic agents in ALL. A subset of drug-resistant T-ALL without mutations in ABL1 is highly responsive to dasatinib, which provides a rationale for drug repurposing.<\/jats:p>","DOI":"10.1182\/blood-2016-09-738070","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T22:00:41Z","timestamp":1485381641000},"page":"e26-e37","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":248,"title":["Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"129","author":[{"given":"Viktoras","family":"Frismantas","sequence":"first","affiliation":[{"name":"Department of Oncology, and"},{"name":"Children\u2019s Research Center, University Children\u2019s Hospital Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pamela","family":"Dobay","sequence":"additional","affiliation":[{"name":"Swiss Institute of Bioinformatics, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"Department of Oncology, and"},{"name":"Children\u2019s Research Center, University Children\u2019s Hospital Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Tchinda","sequence":"additional","affiliation":[{"name":"Department of Oncology, and"},{"name":"Children\u2019s Research Center, University Children\u2019s Hospital Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel H.","family":"Dunn","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Texas Southwestern Medical Center, Dallas, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Kunz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Richter-Pechanska","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blerim","family":"Marovca","sequence":"additional","affiliation":[{"name":"Department of Oncology, and"},{"name":"Children\u2019s Research Center, University Children\u2019s Hospital Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orrin","family":"Pail","sequence":"additional","affiliation":[{"name":"Department of Oncology, and"},{"name":"Children\u2019s Research Center, University Children\u2019s Hospital Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Jenni","sequence":"additional","affiliation":[{"name":"Department of Oncology, and"},{"name":"Children\u2019s Research Center, University Children\u2019s Hospital Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Diaz-Flores","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Helen Diller Family Comprehensive Cancer Center, University of California\u2013San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill H.","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, Doernbecher Children\u2019s Hospital, Oregon Health & Science University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4843-4639","authenticated-orcid":false,"given":"Timothy J.","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, The University of Texas Southwestern Medical Center, Dallas, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Collins","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, The University of Texas Southwestern Medical Center, Dallas, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Uhrig","sequence":"additional","affiliation":[{"name":"German Cancer Research Center, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gnana P.","family":"Balasubramanian","sequence":"additional","affiliation":[{"name":"German Cancer Research Center, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obul R.","family":"Bandapalli","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Higi","sequence":"additional","affiliation":[{"name":"Department of Oncology, and"},{"name":"Children\u2019s Research Center, University Children\u2019s Hospital Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Eugster","sequence":"additional","affiliation":[{"name":"Department of Oncology, and"},{"name":"Children\u2019s Research Center, University Children\u2019s Hospital Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Voegeli","sequence":"additional","affiliation":[{"name":"Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Delorenzi","sequence":"additional","affiliation":[{"name":"Swiss Institute of Bioinformatics, Lausanne, Switzerland;"},{"name":"Ludwig Center for Cancer Research, University of Lausanne, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Cario","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medical Centre Schleswig-Holstein, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mignon L.","family":"Loh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California\u2013San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schrappe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medical Centre Schleswig-Holstein, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stanulla","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas E.","family":"Kulozik","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina U.","family":"Muckenthaler","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaskar","family":"Saha","sequence":"additional","affiliation":[{"name":"Division of Molecular and Clinical Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom;"},{"name":"Tata Translational Cancer Research Centre, Tata Medical Centre, Kolkata, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Irving","sequence":"additional","affiliation":[{"name":"Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Meisel","sequence":"additional","affiliation":[{"name":"Division of Pediatric Stem Cell Therapy, Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich Heine University, D\u00fcsseldorf, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Radimerski","sequence":"additional","affiliation":[{"name":"Disease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend","family":"Von Stackelberg","sequence":"additional","affiliation":[{"name":"German Cancer Research Center, Heidelberg, Germany;"},{"name":"Department of Pediatric Oncology\/Hematology, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany;"},{"name":"German Cancer Consortium, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Eckert","sequence":"additional","affiliation":[{"name":"German Cancer Research Center, Heidelberg, Germany;"},{"name":"Department of Pediatric Oncology\/Hematology, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany;"},{"name":"German Cancer Consortium, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Tyner","sequence":"additional","affiliation":[{"name":"Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Horvath","sequence":"additional","affiliation":[{"name":"Synthetic and Systems Biology Unit, Hungarian Academy of Sciences, Biological Research Center, Szeged, Hungary; and"},{"name":"Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat C.","family":"Bornhauser","sequence":"additional","affiliation":[{"name":"Department of Oncology, and"},{"name":"Children\u2019s Research Center, University Children\u2019s Hospital Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6571-6227","authenticated-orcid":false,"given":"Jean-Pierre","family":"Bourquin","sequence":"additional","affiliation":[{"name":"Department of Oncology, and"},{"name":"Children\u2019s Research Center, University Children\u2019s Hospital Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"14","key":"2019111902543169700_B1","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1182\/blood-2012-02-265884","article-title":"How I treat relapsed childhood acute lymphoblastic leukemia","volume":"120","author":"Locatelli","year":"2012","journal-title":"Blood"},{"issue":"9881","key":"2019111902543169700_B2","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"2019111902543169700_B3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111902543169700_B4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.2532","article-title":"The genomic landscape of hypodiploid acute lymphoblastic leukemia","volume":"45","author":"Holmfeldt","year":"2013","journal-title":"Nat Genet"},{"issue":"5","key":"2019111902543169700_B5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.20110580","article-title":"Gain-of-function mutations in interleukin-7 receptor-\u03b1 (IL7R) in childhood acute lymphoblastic leukemias","volume":"208","author":"Shochat","year":"2011","journal-title":"J Exp Med"},{"issue":"10","key":"2019111902543169700_B6","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1182\/blood.V83.10.2970.2970","article-title":"Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL","volume":"83","author":"Hunger","year":"1994","journal-title":"Blood"},{"issue":"8","key":"2019111902543169700_B7","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/leu.2015.59","article-title":"Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment","volume":"29","author":"Eckert","year":"2015","journal-title":"Leukemia"},{"issue":"11","key":"2019111902543169700_B8","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2014.58.4631","article-title":"Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial","volume":"33","author":"Bader","year":"2015","journal-title":"J Clin Oncol"},{"issue":"15","key":"2019111902543169700_B9","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJMoa1110169","article-title":"Outcomes after induction failure in childhood acute lymphoblastic leukemia","volume":"366","author":"Schrappe","year":"2012","journal-title":"N Engl J Med"},{"issue":"7391","key":"2019111902543169700_B10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature"},{"issue":"7391","key":"2019111902543169700_B11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"issue":"11","key":"2019111902543169700_B12","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.3954","article-title":"High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response","volume":"21","author":"Gao","year":"2015","journal-title":"Nat Med"},{"key":"2019111902543169700_B13","article-title":"Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias","author":"Wang","journal-title":"Leukemia"},{"issue":"4","key":"2019111902543169700_B14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccell.2016.03.008","article-title":"The Public Repository of Xenografts enables discovery and randomized phase II-like trials in mice","volume":"29","author":"Townsend","year":"2016","journal-title":"Cancer Cell"},{"issue":"11","key":"2019111902543169700_B15","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/leu.2016.192","article-title":"A review of new agents evaluated against pediatric acute lymphoblastic leukemia by the Pediatric Preclinical Testing Program","volume":"30","author":"Jones","year":"2016","journal-title":"Leukemia"},{"issue":"12","key":"2019111902543169700_B16","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/2159-8290.CD-13-0350","article-title":"Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia","volume":"3","author":"Pemovska","year":"2013","journal-title":"Cancer Discov"},{"issue":"7541","key":"2019111902543169700_B17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature14119","article-title":"Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation","volume":"519","author":"Pemovska","year":"2015","journal-title":"Nature"},{"issue":"1","key":"2019111902543169700_B18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1158\/0008-5472.CAN-12-1906","article-title":"Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening","volume":"73","author":"Tyner","year":"2013","journal-title":"Cancer Res"},{"issue":"3","key":"2019111902543169700_B19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccell.2015.02.003","article-title":"Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia","volume":"27","author":"Geng","year":"2015","journal-title":"Cancer Cell"},{"issue":"5","key":"2019111902543169700_B20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1365-2141.2003.04217.x","article-title":"Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase","volume":"120","author":"Mihara","year":"2003","journal-title":"Br J Haematol"},{"issue":"22","key":"2019111902543169700_B21","doi-asserted-by":"crossref","first-page":"11501","DOI":"10.18632\/oncotarget.2572","article-title":"Image-based RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support","volume":"5","author":"Boutter","year":"2014","journal-title":"Oncotarget"},{"issue":"4","key":"2019111902543169700_B22","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI39987","article-title":"Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance","volume":"120","author":"Bonapace","year":"2010","journal-title":"J Clin Invest"},{"issue":"7","key":"2019111902543169700_B23","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/blood-2010-11-320309","article-title":"Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment","volume":"118","author":"Schmitz","year":"2011","journal-title":"Blood"},{"issue":"25","key":"2019111902543169700_B24","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1182\/blood-2012-11-468702","article-title":"Leukemia surfaceome analysis reveals new disease-associated features","volume":"121","author":"Mirkowska","year":"2013","journal-title":"Blood"},{"issue":"17","key":"2019111902543169700_B25","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1200\/JCO.2003.11.031","article-title":"Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia","volume":"21","author":"Den Boer","year":"2003","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111902543169700_B26","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nchembio.1367","article-title":"Niche-based screening identifies small-molecule inhibitors of leukemia stem cells","volume":"9","author":"Hartwell","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"9","key":"2019111902543169700_B27","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood.V79.9.2370.2370","article-title":"Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia","volume":"79","author":"Manabe","year":"1992","journal-title":"Blood"},{"issue":"4","key":"2019111902543169700_B28","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI30235","article-title":"Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase","volume":"117","author":"Iwamoto","year":"2007","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111902543169700_B29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3324\/haematol.2015.141101","article-title":"New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia","volume":"101","author":"Moorman","year":"2016","journal-title":"Haematologica"},{"issue":"2","key":"2019111902543169700_B30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat Med"},{"issue":"23","key":"2019111902543169700_B31","doi-asserted-by":"crossref","first-page":"7180","DOI":"10.1158\/1078-0432.CCR-06-1112","article-title":"Dasatinib (BMS-354825) pharmacokinetics and pharmacodynamic biomarkers in animal models predict optimal clinical exposure","volume":"12","author":"Luo","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2019111902543169700_B32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrd3870","article-title":"The role of tumour-stromal interactions in modifying drug response: challenges and opportunities","volume":"12","author":"McMillin","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"23","key":"2019111902543169700_B33","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2014-04-531871","article-title":"Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition","volume":"124","author":"Irving","year":"2014","journal-title":"Blood"},{"issue":"23","key":"2019111902543169700_B34","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.2011.34.8144","article-title":"Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia","volume":"29","author":"Hof","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111902543169700_B35","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.3362","article-title":"Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options","volume":"47","author":"Fischer","year":"2015","journal-title":"Nat Genet"},{"issue":"16","key":"2019111902543169700_B36","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study","volume":"115","author":"Conter","year":"2010","journal-title":"Blood"},{"issue":"339","key":"2019111902543169700_B37","doi-asserted-by":"crossref","first-page":"339ra70","DOI":"10.1126\/scitranslmed.aad2986","article-title":"Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL","volume":"8","author":"McComb","year":"2016","journal-title":"Sci Transl Med"},{"issue":"9757","key":"2019111902543169700_B38","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0140-6736(10)62002-8","article-title":"Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial","volume":"376","author":"Parker","year":"2010","journal-title":"Lancet"},{"issue":"24","key":"2019111902543169700_B39","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1182\/blood-2008-12-197061","article-title":"Therapeutic targeting of MLL","volume":"113","author":"Liedtke","year":"2009","journal-title":"Blood"},{"issue":"7","key":"2019111902543169700_B40","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/0008-5472.CAN-14-1849","article-title":"BH3 inhibitor sensitivity and Bcl-2 dependence in primary acute lymphoblastic leukemia cells","volume":"75","author":"Alford","year":"2015","journal-title":"Cancer Res"},{"issue":"17","key":"2019111902543169700_B41","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1158\/1078-0432.CCR-14-0259","article-title":"Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts","volume":"20","author":"Suryani","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"25","key":"2019111902543169700_B42","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2014-05-574566","article-title":"ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia","volume":"124","author":"Peirs","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2019111902543169700_B43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"issue":"9","key":"2019111902543169700_B44","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1158\/2159-8290.CD-14-0353","article-title":"Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199","volume":"4","author":"Chonghaile","year":"2014","journal-title":"Cancer Discov"},{"issue":"5","key":"2019111902543169700_B45","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1158\/1535-7163.MCT-15-0730","article-title":"Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models","volume":"15","author":"Punnoose","year":"2016","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"2019111902543169700_B46","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ccr.2012.08.027","article-title":"Crosstalk between ROR1 and the Pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemia","volume":"22","author":"Bicocca","year":"2012","journal-title":"Cancer Cell"},{"issue":"10","key":"2019111902543169700_B47","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1016\/j.ejmech.2011.07.050","article-title":"Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities","volume":"46","author":"Fallah-Tafti","year":"2011","journal-title":"Eur J Med Chem"},{"issue":"5","key":"2019111902543169700_B48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: the complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"25","key":"2019111902543169700_B49","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1182\/blood-2011-05-351403","article-title":"Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"118","author":"Fo\u00e0","year":"2011","journal-title":"Blood"},{"key":"2019111902543169700_B50","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2016-03-707414","article-title":"Venetoclax responses of pediatric ALL xenografts reveal MLL-rearranged leukemia","author":"Khaw","year":"2016","journal-title":"Blood"},{"issue":"6059","key":"2019111902543169700_B51","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.1206727","article-title":"Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy","volume":"334","author":"Ni Chonghaile","year":"2011","journal-title":"Science"},{"issue":"5","key":"2019111902543169700_B52","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cell.2015.01.042","article-title":"Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy","volume":"160","author":"Montero","year":"2015","journal-title":"Cell"},{"issue":"10","key":"2019111902543169700_B53","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","article-title":"Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia","volume":"6","author":"Konopleva","year":"2016","journal-title":"Cancer Discov"},{"issue":"3","key":"2019111902543169700_B54","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/leu.2008.318","article-title":"Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia","volume":"23","author":"Deenik","year":"2009","journal-title":"Leukemia"},{"issue":"19","key":"2019111902543169700_B55","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1200\/JCO.2012.46.8280","article-title":"Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium","volume":"31","author":"Zwaan","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/11\/e26\/1398870\/blood738070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/11\/e26\/1398870\/blood738070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:54:49Z","timestamp":1574132089000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/11\/e26\/35924\/Ex-vivo-drug-response-profiling-detects-recurrent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,16]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,3,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-09-738070","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,16]]}}}